CoChat

The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.

Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation

Open access

Abstract

The present study examined the roles of peroxisome proliferator-activated receptors (PPAR) in activation of hepatic stellate cells (HSC), a pivotal event in liver fibrogenesis. RNase protection assay detected mRNA for PPARgamma1 but not that for the adipocyte-specific gamma2 isoform in HSC isolated from sham-operated rats, whereas the transcripts for neither isoforms were detectable in HSC from cholestatic liver fibrosis induced by bile duct ligation (BDL). Semi-quantitative reverse transcriptase-polymerase chain reaction confirmed a 70% reduction in PPARgamma mRNA level in HSC from BDL. Nuclear extracts from BDL cells showed an expected diminution of binding to PPAR-responsive element, whereas NF-kappaB and AP-1 binding were increased. Treatment of cultured-activated HSC with ligands for PPARgamma (10 microm 15-deoxy-Delta(12,14)-PGJ(2) (15dPGJ(2)); 0.1 approximately 10 microm BRL49653) inhibited DNA and collagen synthesis without affecting the cell viability. Suppression of HSC collagen by 15dPGJ(2) was abrogated 70% by the concomitant treatment with a PPARgamma antagonist (GW9662). HSC DNA and collagen synthesis were inhibited by WY14643 at the concentrations known to activate both PPARalpha and gamma (>100 microm) but not at those that only activate PPARalpha (<10 microm) or by a synthetic PPARalpha-selective agonist (GW9578). 15dPGJ(2) reduced alpha1(I) procollagen, smooth muscle alpha-actin, and monocyte chemotactic protein-1 mRNA levels while inducing matrix metalloproteinase-3 and CD36. 15dPGJ(2) and BRL49653 inhibited alpha1(I) procollagen promoter activity. Tumor necrosis factor alpha (10 ng/ml) reduced PPARgamma mRNA, and this effect was prevented by the treatment with 15dPGJ(2). These results demonstrate that HSC activation is associated with the reductions in PPARgamma expression and PPAR-responsive element binding in vivo and is reversed by the treatment with PPARgamma ligands in vitro. These findings implicate diminished PPARgamma signaling in molecular mechanisms underlying activation of HSC in liver fibrogenesis and the potential therapeutic value of PPARgamma ligands for liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m006577200

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1 RNase protection assay for PPAR g 1 and g 2 transcripts. RNase protection assay was performed on samples (5 m g each) extracted from rat epididymal fat (first lane ), rat liver (third lane ), hepatic stellate cells isolated from a sham-operated rat (HSC-sham, fourth lane ), and hepatic stellate cells from a 7-day bile duct-ligated rat (HSC-BDL, fifth lane ). Note the abundant expression of both forms of PPAR g in the fat sample. Even though the level of expression is much less, the liver RNA also contains both forms of PPAR g . However, only the PPAR g 1 transcript, but not an adipocyte specific PPAR g 2, is detected in the RNA sample from HSC-sham, and the PPAR g 1 expression is diminished in HSC-BDL.
FIG. 1 RNase protection assay for PPAR g 1 and g 2 transcripts. RNase protection assay was performed on samples (5 m g each) extracted from rat epididymal fat (first lane ), rat liver (third lane ), hepatic stellate cells isolated from a sham-operated rat (HSC-sham, fourth lane ), and hepatic stellate cells from a 7-day bile duct-ligated rat (HSC-BDL, fifth lane ). Note the abundant expression of both forms of PPAR g in the fat sample. Even though the level of expression is much less, the liver RNA also contains both forms of PPAR g . However, only the PPAR g 1 transcript, but not an adipocyte specific PPAR g 2, is detected in the RNA sample from HSC-sham, and the PPAR g 1 expression is diminished in HSC-BDL.CC-BY · From the PDF
FIG. 2 A , PPAR g mRNAis reduced in HSC from 7-day BDL animals. RT-PCR demonstrates moderately reduced mRNA expression of PPAR g in HSC from the 7-day BDL animals, whereas induction of activation marker genes such as a 1(I) procollagen ( a 1(I) Coll ) and a -SMA are evident in these cells. B , both PPAR a and PPAR g are suppressed in HSC from 19-day BDL animals. RT-PCR was performed as above on HSC RNA samples from rats 19 days after sham or BDL operation. Note the consistent reduction in the mRNA level of PPAR a and PPAR g in HSC from BDL animals. C , semi-quantitative densitometric analysis of the RT-PCR data depicting significantly (*, p , 0.05) decreased mRNA levels of PPAR a and PPAR g in HSC from 19-day BDL animals.
FIG. 2 A , PPAR g mRNAis reduced in HSC from 7-day BDL animals. RT-PCR demonstrates moderately reduced mRNA expression of PPAR g in HSC from the 7-day BDL animals, whereas induction of activation marker genes such as a 1(I) procollagen ( a 1(I) Coll ) and a -SMA are evident in these cells. B , both PPAR a and PPAR g are suppressed in HSC from 19-day BDL animals. RT-PCR was performed as above on HSC RNA samples from rats 19 days after sham or BDL operation. Note the consistent reduction in the mRNA level of PPAR a and PPAR g in HSC from BDL animals. C , semi-quantitative densitometric analysis of the RT-PCR data depicting significantly (*, p , 0.05) decreased mRNA levels of PPAR a and PPAR g in HSC from 19-day BDL animals.CC-BY · From the PDF
FIG. 3 PPRE binding is diminished in HSC from 19-day BDL animals. Nuclear extracts (10 m g of protein per sample) from HSC isolated from 19-day sham or BDL animals were analyzed by electrophoretic mobility shift assay for binding to PPRE, NF-kB, or AP-1 site as described under 'Materials and Methods.' Note PPRE binding is diminished in HSC from BDL animals, whereas NF-kB and AP-1 binding are enhanced. The last lane of the upper panel shows a supershift assay with anti-PPAR g antibodies, resulting in diminution of the binding by the sham HSC nuclear extracts and the appearance of a supershifted band ( arrow ). The use of non-immune antibodies did not affect the binding pattern (data now shown N.S. refers to nonspecific binding).
FIG. 3 PPRE binding is diminished in HSC from 19-day BDL animals. Nuclear extracts (10 m g of protein per sample) from HSC isolated from 19-day sham or BDL animals were analyzed by electrophoretic mobility shift assay for binding to PPRE, NF-kB, or AP-1 site as described under 'Materials and Methods.' Note PPRE binding is diminished in HSC from BDL animals, whereas NF-kB and AP-1 binding are enhanced. The last lane of the upper panel shows a supershift assay with anti-PPAR g antibodies, resulting in diminution of the binding by the sham HSC nuclear extracts and the appearance of a supershifted band ( arrow ). The use of non-immune antibodies did not affect the binding pattern (data now shown N.S. refers to nonspecific binding).CC-BY · From the PDF
FIG. 4 A , PPAR g (15dPGJ2, BRL49653) ligands inhibit HSC DNA and collagen synthesis. The 3-4-day primary cultures of HSC were exposed to 15dPGJ2 (1 and 10 m M), BRL49653 (1 and 10 m M), or WY14643 (10 ; 250 m M) for 18 h, and [ 3 H]thymidine incorporation into DNA was assessed. Note a significant, ; 40%, inhibition in HSC DNA synthesis by 15dPGJ2 and BRL49653 at 10 m M and WY14643 at 100 and 250 m M. *, p , 0.05; **, p , 0.01 compared with the respective control. DMSO , Me2SO. B , collagen production by cultured HSC, as determined by incorporation of [ 3 H]proline into collagenase-sensitive peptides was significantly inhibited by 18 h of treatment with 15dPGJ 2 (10 m M), BRL49653 (0.1 ; 10 m M), and WY14643 (100 m M). *, p , 0.05; **,
FIG. 4 A , PPAR g (15dPGJ2, BRL49653) ligands inhibit HSC DNA and collagen synthesis. The 3-4-day primary cultures of HSC were exposed to 15dPGJ2 (1 and 10 m M), BRL49653 (1 and 10 m M), or WY14643 (10 ; 250 m M) for 18 h, and [ 3 H]thymidine incorporation into DNA was assessed. Note a significant, ; 40%, inhibition in HSC DNA synthesis by 15dPGJ2 and BRL49653 at 10 m M and WY14643 at 100 and 250 m M. *, p , 0.05; **, p , 0.01 compared with the respective control. DMSO , Me2SO. B , collagen production by cultured HSC, as determined by incorporation of [ 3 H]proline into collagenase-sensitive peptides was significantly inhibited by 18 h of treatment with 15dPGJ 2 (10 m M), BRL49653 (0.1 ; 10 m M), and WY14643 (100 m M). *, p , 0.05; **,CC-BY · From the PDF
FIG. 5 Suppression of activation marker genes in cultured HSC with 15dPGJ2 or WY14643. A , messenger RNA expression for a 1(I) procollagen ( a 1(I)Coll ), a -SMA, and MCP-1 is inhibited by 15dPGJ2 (10 m M), whereas MMP-3 was induced by the ligand in the 3-4-day-cultured HSC ( left panel ). The cells treated with TNF a responded similarly to 15dPGJ 2 ( right panel ). B , expression of CD36 was induced in 15dPGJ2-treated HSC as compared with the cells treated with a vehicle control (Me 2SO ( DMSO )). C , WY14643 (100 m M) suppressed a 1(I) procollagen and a -SMA mRNA expression but induced MMP-13 expression by cultured HSC. DMSO , Me2SO.
FIG. 5 Suppression of activation marker genes in cultured HSC with 15dPGJ2 or WY14643. A , messenger RNA expression for a 1(I) procollagen ( a 1(I)Coll ), a -SMA, and MCP-1 is inhibited by 15dPGJ2 (10 m M), whereas MMP-3 was induced by the ligand in the 3-4-day-cultured HSC ( left panel ). The cells treated with TNF a responded similarly to 15dPGJ 2 ( right panel ). B , expression of CD36 was induced in 15dPGJ2-treated HSC as compared with the cells treated with a vehicle control (Me 2SO ( DMSO )). C , WY14643 (100 m M) suppressed a 1(I) procollagen and a -SMA mRNA expression but induced MMP-13 expression by cultured HSC. DMSO , Me2SO.CC-BY · From the PDF
FIG. 6 Inhibition of a 1(I) collagen gene promoter with 15dPGJ2 and BRL49653. Cultured HSC after the first passage were co-transfected with an a 1(I) collagen promoter and a PPAR g expression vector and exposed to 15dPGJ 2 (10 m M) or BRL49653 (10 m M). Luciferase activities were normalized by protein concentrations and expressed as the relative expression to that without ligand treatment. Note significant, 60 and 50%, reductions in the promoter activity caused by 15dPGJ2 and BRL49653, respectively.
FIG. 6 Inhibition of a 1(I) collagen gene promoter with 15dPGJ2 and BRL49653. Cultured HSC after the first passage were co-transfected with an a 1(I) collagen promoter and a PPAR g expression vector and exposed to 15dPGJ 2 (10 m M) or BRL49653 (10 m M). Luciferase activities were normalized by protein concentrations and expressed as the relative expression to that without ligand treatment. Note significant, 60 and 50%, reductions in the promoter activity caused by 15dPGJ2 and BRL49653, respectively.CC-BY · From the PDF
FIG. 7 Morphological changes in cultured HSC exposed to 15dPGJ2. Representative differential interference contrast and fluorescent images of the 7-day-cultured HSC exposed to the carrier ( A , B , and C ) or 10 m M ( D , E , and F ) 15dPGJ2. Differential interference contrast images are presented in the left column ( A and D ). Cells stained for actin stress fibers are displayed in the middle column ( B and E ); cells stained for focal adhesion complexes are displayed in the right column ( C and F ).
FIG. 7 Morphological changes in cultured HSC exposed to 15dPGJ2. Representative differential interference contrast and fluorescent images of the 7-day-cultured HSC exposed to the carrier ( A , B , and C ) or 10 m M ( D , E , and F ) 15dPGJ2. Differential interference contrast images are presented in the left column ( A and D ). Cells stained for actin stress fibers are displayed in the middle column ( B and E ); cells stained for focal adhesion complexes are displayed in the right column ( C and F ).CC-BY · From the PDF
Image 8
CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Research works printed but not linked: 8

  1. Friedman, 1993, Am. J. Physiol., 264, G947
  2. Tsukamoto, 1996, Am. J. Physiol., 270, G581
  3. Salbert, 1993, Mol. Endocrinol., 7, 1347
  4. Okuno, 1997, Hepatology, 26, 913
  5. Potter, 1998, Biochem. Cell Biol., 244, 178
  6. Lin, 1997, Am. J. Physiol., 272, G1355
  7. Rippe, 1995, Hepatology, 22, 241
  8. Zhang, 1996, Mol. Endocrinol., 10, 1457

Cited by

See all 477

Metadata

Authors
Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H. F., Motomura, K., Anania, F. A., Willson, T. M., & Tsukamoto, H.
Affiliations
  • University of Southern California (US)
  • University of North Carolina at Chapel Hill (US)
  • University of California, Los Angeles (US)
  • University of Maryland, College Park (US)
Corresponding author
Tsukamoto, Hidekazu
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2000-11
Volume
275
Issue
46
Pages
35715-35722
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2025657436
Cited by
473
References
56
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 18 · 2019: 14 · 2018: 14 · 2017: 19 · 2016: 16 · 2015: 22 · 2014: 21 · 2013: 17 · 2012: 25
FWCI
5.31
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • U.S. Department of Veterans Affairs
  • University of Southern California (DK48522)
  • National Institutes of Health (5k08dk002450-05, AA10459)
  • National Institute on Alcohol Abuse and Alcoholism (AA10459, R37AA006603, R37-AA-06603, P50AA011999)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-02450)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
peroxisome proliferator-activated receptors, PPARγ, hepatic stellate cell activation, liver fibrosis, cholestatic liver fibrosis, bile duct ligation, PPAR ligands, collagen synthesis, PPAR-responsive element, TNF-α, matrix metalloproteinase-3
MeSH terms
Rosiglitazone, Animals, Cell Survival, Cells, Cultured, Collagen, DNA, Gene Expression Regulation, Liver, Liver Cirrhosis, Biliary, Liver Cirrhosis, Experimental, Male, Promoter Regions, Genetic, Protein Binding, Pyrimidines, RNA, Messenger, Thiazoles, Transcription Factors, Tumor Necrosis Factor-alpha, Prostaglandin D2, Rats, Wistar, Receptors, Cytoplasmic and Nuclear, Protein Isoforms, Thiazolidinediones, Cell Size, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation. https://app.cochat.ai/papers/10.1074/jbc.m006577200
The paper
Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H. F., Motomura, K., Anania, F. A., Willson, T. M., & Tsukamoto, H. (2000). Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m006577200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.